This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 26334075
Submitted by lobbyist on: February 2, 2016 10:42:54 AM
Accepted by Registrar on: February 4, 2016 01:35:19 PM
Designated Filer Information
Weiss, Martin |
30 Eglinton Avenue West Suite 760 | |
Mississauga, ON, L5R 3E7
|
905-755-2215 |
Canada |
Organization Information
Vertex Pharmaceuticals (Canada) Inc. |
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines to treat people with serious diseases. Vertex has a commercial office in Ontario and a research and development site in Quebec. |
30 Eglinton Avenue West Suite 760 | |
Mississauga, ON, L5R 3E7
|
647-466-0984 |
Canada |
Relevant Affiliates
Type:
Business Name | Mailing Address | Contact Information |
---|---|---|
Vertex Pharmaceuticals Inc. |
50 Northern Avenue
Boston, MA 02210 United States of America |
Phone: |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
February 2, 2016 | |
July 31, 2016 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder for purpose of lobbying
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
The listing and reimbursement of Health Canada approved Vertex medicines for eligible patients in British Columbia.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 2, 2016 | |
Staff of Minister | Minister of Health | May 25, 2016 | |
Minister | Lake, Terry | Minister of Health | May 25, 2016 |
MLA | Ashton, Dan | Penticton | May 25, 2016 |
MLA | Bing, Doug | Maple Ridge-Pitt Meadows | May 25, 2016 |
MLA | Cadieux, Stephanie | Surrey-Cloverdale | May 25, 2016 |
MLA | Hamilton, Scott | Delta North | May 25, 2016 |
MLA | Hunt, Marvin | Surrey-Panorama | May 25, 2016 |
MLA | James, Carole | Victoria-Beacon Hill | May 25, 2016 |
MLA | Kyllo, Greg | Shuswap | May 25, 2016 |
MLA | Lake, Terry | Kamloops-North Thompson | May 25, 2016 |
MLA | McRae, Don | Comox Valley | May 25, 2016 |
MLA | Plecas, Darryl | Abbotsford South | May 25, 2016 |
MLA | Polak, Mary | Langley | May 25, 2016 |
MLA | Reimer, Linda | Port Moody-Coquitlam | May 25, 2016 |
MLA | Simpson, Shane | Vancouver-Hastings | May 25, 2016 |
MLA | Stilwell, Michelle | Parksville-Qualicum | May 25, 2016 |
MLA | Stilwell, Moira | Vancouver-Langara | February 2, 2016 |
MLA | Sullivan, Sam | Vancouver-False Creek | May 25, 2016 |
MLA | Sultan, Ralph | West Vancouver-Capilano | May 25, 2016 |
MLA | Thornthwaite, Jane | North Vancouver-Seymour | May 25, 2016 |
MLA | Throness, Laurie | Chilliwack-Kent | May 25, 2016 |
MLA | Trevena, Claire | North Island | May 25, 2016 |
MLA | Yap, John | Richmond-Steveston | February 2, 2016 |
Public Agency | Health | May 25, 2016 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
Development, establishment, amendment or termination of any program, policy or decision
The listing and reimbursement of Health Canada approved Vertex medicines to treat eligible patients in British Columbia.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Premier | February 2, 2016 | |
MLA | Stilwell, Moira | Vancouver-Langara | February 2, 2016 |
MLA | Yap, John | Richmond-Steveston | February 2, 2016 |